{"id":37148,"date":"2021-11-22T14:45:50","date_gmt":"2021-11-22T14:45:50","guid":{"rendered":"https:\/\/www.biotechpharmasummit.com\/?page_id=37148"},"modified":"2021-11-22T15:13:40","modified_gmt":"2021-11-22T15:13:40","slug":"bernhard-mullinger","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/bernhard-mullinger\/","title":{"rendered":"Bernhard M\u00fcllinger"},"content":{"rendered":"<div class=\"vgblk-rw-wrapper limit-wrapper\">\n\n\t<h2>Bernhard M\u00fcllinger<\/h2>\n<h4>General Manager, Chief Operating Officer at Resyca<\/h4>\n\t<p>Bernhard M\u00fcllinger is Chief Operating Officer General Manager at Resyca. With the resyca team he provides seamless outsourcing services for drug-device combination products in liquid formulations.\u00a0He has worked on smart nebuliser devices and has extensive experience in medical device development and clinical development of combination products. Before joining Resyca Bernhard has worked at Vectura, Activaero, Inamed-CRO, at the Asklepios Clinic and at the Helmholtz-Zentrum.<\/p>\n\t\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/bernhard-muellinger_reysa_BioTech_Pharma_Summit_gallery.jpg\" alt=\"bernhard muellinger_reysa_BioTech_Pharma_Summit_gallery\" itemprop=\"image\" height=\"1224\" width=\"820\" title=\"bernhard muellinger_reysa_BioTech_Pharma_Summit_gallery\" onerror=\"this.style.display='none'\"  sizes=\"auto, (max-width: 768px) 100vw, 100vw\" srcset=\"data:image\/svg+xml;utf8,&lt;svg%20xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;%20viewBox=&quot;0%200%20820%201224&quot;%20height=&quot;1224px&quot;%20width=&quot;820px&quot;\/&gt;\" data-srcset=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/bernhard-muellinger_reysa_BioTech_Pharma_Summit_gallery.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/bernhard-muellinger_reysa_BioTech_Pharma_Summit_gallery-201x300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/bernhard-muellinger_reysa_BioTech_Pharma_Summit_gallery-686x1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/bernhard-muellinger_reysa_BioTech_Pharma_Summit_gallery-768x1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/bernhard-muellinger_reysa_BioTech_Pharma_Summit_gallery-630x940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/bernhard-muellinger_reysa_BioTech_Pharma_Summit_gallery-420x627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/bernhard-muellinger_reysa_BioTech_Pharma_Summit_gallery-315x470.jpg 315w\" \/>\t\t\t\t\t\t\t\n<h3>\n\tTitle: Biologics Delivered in Liquid Form by Soft-Mist-Inhalers (SMI)\n\t<\/h3>\n\t<ul>\n<li>Liquid formulations in inhaled drug-device combination products<\/li>\n<li>Soft Mist Inhaler technology using pre-filled syringes for delivery of high doses to the lungs<\/li>\n<li>Standard filling process appropriate for early stage and commercial<\/li>\n<\/ul>\n<h4>\n\t\t\t<a href=\"#\" title=\"On the Web\" target=\"_self\" rel=\"noopener\">\n\tOn the Web\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/resyca.com\/\" target=\"_blank\" rel=\"noopener\">https:\/\/resyca.com\/<\/a><\/p>\n<h4>\n\t\t\t<a href=\"#\" title=\"On LinkedIn\" target=\"_self\" rel=\"noopener\">\n\tOn LinkedIn\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/www.linkedin.com\/in\/bernhard-m%C3%BCllinger-2138a06\/\" target=\"_blank\" rel=\"noopener\">Visit Profile<\/a><\/p>\n\n<\/div><!-- .vgblk-rw-wrapper -->","protected":false},"excerpt":{"rendered":"<p>Bernhard M\u00fcllinger General Manager, Chief Operating Officer at Resyca Bernhard M\u00fcllinger is Chief Operating Officer General Manager at Resyca. With the resyca team he provides seamless outsourcing services for drug-device combination products in liquid formulations.\u00a0He has worked on smart nebuliser devices and has extensive experience in medical device development and clinical development of combination products&#8230;.<\/p>\n","protected":false},"author":1,"featured_media":37149,"parent":15585,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-37148","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Bernhard M\u00fcllinger &#8226; BioTech Pharma Summit<\/title>\n<meta name=\"description\" content=\"Bernhard M\u00fcllinger is Chief Operating Officer General Manager at Resyca. With the resyca team he provides seamless outsourcing services for drug-device combination products in liquid formulations.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/bernhard-mullinger\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bernhard M\u00fcllinger &#8226; BioTech Pharma Summit\" \/>\n<meta property=\"og:description\" content=\"Bernhard M\u00fcllinger is Chief Operating Officer General Manager at Resyca. With the resyca team he provides seamless outsourcing services for drug-device combination products in liquid formulations.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/bernhard-mullinger\/\" \/>\n<meta property=\"og:site_name\" content=\"BioTech Pharma Summit\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/biotechpharmasummit\/\" \/>\n<meta property=\"article:modified_time\" content=\"2021-11-22T15:13:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/bernhard_muellinger_Reysa_BioTech_Pharma_Summit_2021_profile.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@biotechsummit\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/bernhard-mullinger\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/bernhard-mullinger\/\",\"name\":\"Bernhard M\u00fcllinger &#8226; BioTech Pharma Summit\",\"isPartOf\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/bernhard-mullinger\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/bernhard-mullinger\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/bernhard_muellinger_Reysa_BioTech_Pharma_Summit_2021_profile.jpg\",\"datePublished\":\"2021-11-22T14:45:50+00:00\",\"dateModified\":\"2021-11-22T15:13:40+00:00\",\"description\":\"Bernhard M\u00fcllinger is Chief Operating Officer General Manager at Resyca. With the resyca team he provides seamless outsourcing services for drug-device combination products in liquid formulations.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/bernhard-mullinger\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/bernhard-mullinger\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/bernhard-mullinger\/#primaryimage\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/bernhard_muellinger_Reysa_BioTech_Pharma_Summit_2021_profile.jpg\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/bernhard_muellinger_Reysa_BioTech_Pharma_Summit_2021_profile.jpg\",\"width\":900,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/bernhard-mullinger\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Inhalation &#038; Respiratory Drug Delivery 2021 Speakers\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Bernhard M\u00fcllinger\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"name\":\"BioTech Pharma Summit\",\"description\":\"The Tomorrow&#039;s healthcare congress\",\"publisher\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\",\"name\":\"EPM Group\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"width\":2000,\"height\":2000,\"caption\":\"EPM Group\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/biotechpharmasummit\/\",\"https:\/\/x.com\/biotechsummit\",\"https:\/\/www.instagram.com\/biotechpharmasummit\/\",\"https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bernhard M\u00fcllinger &#8226; BioTech Pharma Summit","description":"Bernhard M\u00fcllinger is Chief Operating Officer General Manager at Resyca. With the resyca team he provides seamless outsourcing services for drug-device combination products in liquid formulations.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/bernhard-mullinger\/","og_locale":"en_US","og_type":"article","og_title":"Bernhard M\u00fcllinger &#8226; BioTech Pharma Summit","og_description":"Bernhard M\u00fcllinger is Chief Operating Officer General Manager at Resyca. With the resyca team he provides seamless outsourcing services for drug-device combination products in liquid formulations.","og_url":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/bernhard-mullinger\/","og_site_name":"BioTech Pharma Summit","article_publisher":"https:\/\/www.facebook.com\/biotechpharmasummit\/","article_modified_time":"2021-11-22T15:13:40+00:00","og_image":[{"width":900,"height":900,"url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/bernhard_muellinger_Reysa_BioTech_Pharma_Summit_2021_profile.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@biotechsummit","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/bernhard-mullinger\/","url":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/bernhard-mullinger\/","name":"Bernhard M\u00fcllinger &#8226; BioTech Pharma Summit","isPartOf":{"@id":"https:\/\/www.biotechpharmasummit.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/bernhard-mullinger\/#primaryimage"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/bernhard-mullinger\/#primaryimage"},"thumbnailUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/bernhard_muellinger_Reysa_BioTech_Pharma_Summit_2021_profile.jpg","datePublished":"2021-11-22T14:45:50+00:00","dateModified":"2021-11-22T15:13:40+00:00","description":"Bernhard M\u00fcllinger is Chief Operating Officer General Manager at Resyca. With the resyca team he provides seamless outsourcing services for drug-device combination products in liquid formulations.","breadcrumb":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/bernhard-mullinger\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/bernhard-mullinger\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/bernhard-mullinger\/#primaryimage","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/bernhard_muellinger_Reysa_BioTech_Pharma_Summit_2021_profile.jpg","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/bernhard_muellinger_Reysa_BioTech_Pharma_Summit_2021_profile.jpg","width":900,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/bernhard-mullinger\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biotechpharmasummit.com\/"},{"@type":"ListItem","position":2,"name":"Inhalation &#038; Respiratory Drug Delivery 2021 Speakers","item":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/"},{"@type":"ListItem","position":3,"name":"Bernhard M\u00fcllinger"}]},{"@type":"WebSite","@id":"https:\/\/www.biotechpharmasummit.com\/#website","url":"https:\/\/www.biotechpharmasummit.com\/","name":"BioTech Pharma Summit","description":"The Tomorrow&#039;s healthcare congress","publisher":{"@id":"https:\/\/www.biotechpharmasummit.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.biotechpharmasummit.com\/#organization","name":"EPM Group","url":"https:\/\/www.biotechpharmasummit.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","width":2000,"height":2000,"caption":"EPM Group"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/biotechpharmasummit\/","https:\/\/x.com\/biotechsummit","https:\/\/www.instagram.com\/biotechpharmasummit\/","https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/37148","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/comments?post=37148"}],"version-history":[{"count":3,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/37148\/revisions"}],"predecessor-version":[{"id":37155,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/37148\/revisions\/37155"}],"up":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/15585"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media\/37149"}],"wp:attachment":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media?parent=37148"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}